Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Fast Is The Inhalation CDMO Market Expected to Grow Between 2025 And 2029?
In the past few years, the market size for inhalation CDMO has seen a robust growth. The prediction is that it will rise from $2.08 billion in 2024 to $2.2 billion in 2025, with a compound annual growth rate (CAGR) of 6.0%. The historical growth trend can be credited to factors such as the increasing incidences of respiratory diseases, the growing preference for personalized medication, rising trend of outsourcing by pharmaceutical firms, and expansion of the biopharmaceutical sector.
In the coming years, the inhalation CDMO market is projected to experience robust growth. It’s expected to reach a value of $2.84 billion in 2029, with a compound annual growth rate (CAGR) of 6.5%. The anticipated growth during this period can be linked to a myriad of factors. These include a focus on precision medicine and targeted therapies, the swift expansion of biopharmaceutical inhalation therapies, concentration on patient-centric solutions, overall market growth, and the emergence of new market opportunities. Furthermore, regulatory support for the development of inhalation drugs is also a contributing factor. Key trends for this period include a rising demand for digital health solutions, biologic inhalation therapies, emphasis on environmentally-friendly inhaler technologies, and the integration of artificial intelligence (AI) and machine learning. Collaborations and partnerships also play a significant role in this forecasted growth.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13864&type=smp
What Are the Primary Drivers Supporting the Market Growth of the Inhalation CDMO Market?
The escalating occurrence of respiratory diseases is forecasted to fuel the expansion of the inhalation CDMO market. These disorders encompass a range of health issues that impact the respiratory system, involving varied organs and mechanisms associated with respiration. These inhalation CDMOs are utilized in the creation and production of products addressing respiratory diseases, owing to their proficiency in formulating and transporting drugs to the lungs. They provide specialized knowledge, facilities, and resources to pharmaceutical establishments aiming to introduce novel inhalation therapies. As per the Australian Bureau of Statistics (ABS), a government agency in Australia, it estimated that 8.5 million Australians (34%) suffered from chronic respiratory ailments, which includes 2.8 million individuals (11%) with asthma, and 638,000 individuals (2.5%) with COPD. Thus, the escalating occurrence of respiratory disorders is inducing the expansion of the inhalation CDMO market.
Which Primary Segments of the Inhalation CDMO Market Are Driving Growth and Industry Transformations?
The inhalation cdmo market covered in this report is segmented –
1) By Product: Dry Powder Inhaler (DPIs), Metered Dose Inhaler (MDIs), Nebulizer, Soft Mist Inhaler
2) By Disease Indication: Asthma, Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Arterial Hypertension, Acute Respiratory Distress Syndrome, Pulmonary Fibrosis
3) By Technology: Manual Inhalers (SMI), Digital Inhalers
4) By End-User: Big Pharmaceutical Companies, Small and Medium-sized Pharmaceutical Companies, Generic Pharmaceutical Companies, Other End-Users
Subsegments:
1) By Dry Powder Inhaler (DPIs): Capsule-Based DPIs, Diskus-Style DPIs, Multi-Dose DPIs, Unit-Dose DPIs
2) By Metered Dose Inhaler (MDIs): Pressurized MDIs (pMDIs), Breath-Actuated MDIs, Soft Mist MDIs
3) By Nebulizer: Jet Nebulizers, Ultrasonic Nebulizers, Mesh Nebulizers, Portable Nebulizers
4) By Soft Mist Inhaler: Respimat Inhalers, Other Soft Mist Inhalation Devices
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=13864&type=smp
Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of the Inhalation CDMO Market?# Market?
North America was the largest region in the inhalation contract development and manufacturing organization (CDMO) market in 2024. The regions covered in the inhalation CDMO market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Most Significant Market Trends in the Inhalation CDMO Market?
Leading corporations in the inhalation CDMO market are opting for a strategic partnership model to offer specialized services in drug development and delivery. Such strategic partnerships are long-lasting and mutually beneficial contracts between two or more firms that cooperate to fulfill common objectives. For example, in May 2023, Hovione, a Portuguese Contract Development and Manufacturing Organization, teamed up with H&T Presspart, a British producer of metal and plastic components for the pharmaceutical industry, to work on Presspart’s Sunrise Capsule-based Dry Powder Inhaler platform. The goal of this alliance is to create innovative technologies capable of delivering greater drug dosages and enhancing the efficacy of delivering drugs to the lungs.
View the full report here:
https://www.thebusinessresearchcompany.com/report/inhalation-cdmo-global-market-report
What Parameters Are Used to Define the Inhalation CDMO Market?
An inhalation contract development and manufacturing organization (CDMO) is a specialized organization that provides comprehensive services to pharmaceutical and biotechnology firms for the development and manufacturing of inhalable drugs. These organizations offer a range of services tailored specifically to the needs of inhalation products, including formulation development, analytical testing, process optimization, scale-up, and commercial manufacturing.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13864
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model